We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
To meet the ever-increasing demand of growing domestic pharmaceutical markets, the AccelTRA® Components Program has expanded to include an RTS/RTU product line with Ready-to-Sterilize (RTS) and Ready-to-Use (RTU) gamma sterilized stoppers developed to provide an innovative customer service package to help customers get their products to market quickly.
How do AccelTRA® RTS/RTU components meet customers’ premium domestic needs?
The AccelTRA RTS/RTU product line is designed specifically for customers manufacturing in or exporting to non-North American markets to help meet either their premium domestic market needs or export needs to Europe, Asia Pacific, and elsewhere.
AccelTRA RTS/ RTU stoppers are available with features that address customers’ technical requirements. The AccelTRA components program also supports customers with optimized lead times, helping them get their products to their desired markets quickly.
AccelTRA RTS/RTU components are to be considered by pharmaceutical companies because of following reasons:
These features help customers platform their drug products with AccelTRA® RTS/RTU components, thus standardizing on “one” elastomer offering to reduce overall stopper SKUs and inventory costs to address their premium domestic or export needs for non-North American markets.
West understands domestic market requirements and has developed aprogram that will help address customers’ needs with Quality, Speedand Simplicity. Learn more about the AccelTRA Component Program and the AccelTRA RTS/RTU components here.
AccelTRA® and logo are registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Recently, the generics pharmaceutical industry in the United States has seen the average time to market decrease significantly as approvals have steadily increased thanks to the introduction of the Generic Drug User Fee Amendments (GDUFA) in October 2012. The reduction in time has led pharmaceutical companies to seek out high-quality elastomer products that provide the regulatory simplicity necessary to bring their products to market quickly, helping to increase a company’s competitiveness and their drug product’s overall sales. The AccelTRA™ elastomer program is built on these features: Quality, Speed, Simplicity.<br />
West is pleased to announce that the AccelTRA™ component program has been recognized with a 2018 India Packaging Award in the category of “Packaging Design in Injectables.” The award was announced during a ceremony at the 2018 InnoPack Pharma Confex in Mumbai, India on May 24, 2018.
For any drug, selection of the appropriate primary packaging components is essential to having a containment system that ensures quality, safety, and stability. The primary packaging components are selected based on various factors, which include chemical compatibility with the drug product ingredients and dimensional fit with mating packaging components. Optimized fit among mating packaging components is essential for flawless fill-finish processing.
The AccelTRA<sup>®</sup> components program was developed to help generics manufacturers meet increasing quality standards, facilitate fast response to market variability and standardize around a next generation formulation for simplicity. Initially introduced with stopper configurations in 13mm and 20mm serum and lyo formats, the benefits under the program support the needs of the generics market to minimize the risk for quality by having an industry leading Extractables package, in addition to an optimized supply chain, ensuring 6-week lead times on commercial orders.
When faced with drug shortages or supply chain issues affecting a branded drug product, generic drug manufacturers need to move quickly to help ensure that needed therapies reach the market safely and efficiently. Access to high-quality packaging and delivery components can make a huge difference in ensuring patients receive life-saving medications on schedule.
English
Chinese
